63.31
0.92%
+0.58
iShares U.S. Pharmaceuticals ETF stock is currently priced at $63.31, with a 24-hour trading volume of 23,808.
It has seen a +0.92% increased in the last 24 hours and a -5.10% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $62.90 pivot point. If it approaches the $63.50 resistance level, significant changes may occur.
Previous Close:
$62.73
Open:
$62.77
24h Volume:
23,808
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.46%
1M Performance:
-5.10%
6M Performance:
-62.76%
1Y Performance:
-64.49%
iShares U.S. Pharmaceuticals ETF Stock (IHE) Company Profile
Name
iShares U.S. Pharmaceuticals ETF
Sector
Industry
Phone
800-474-2737
Address
-
iShares U.S. Pharmaceuticals ETF Stock (IHE) Latest News
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
Zacks Investment Research
JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus
Zacks Investment Research
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
Zacks Investment Research
Time to Tap Healthcare ETFs on Nvidia's AI Ambition?
Zacks Investment Research
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Zacks Investment Research
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
Zacks Investment Research
iShares U.S. Pharmaceuticals ETF Stock (IHE) Financials Data
There is no financial data for iShares U.S. Pharmaceuticals ETF (IHE). Check out other stocks for more information.
About iShares U.S. Pharmaceuticals ETF
The investment seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index.
The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The fund is non-diversified.
Cap:
|
Volume (24h):